1. |
Bos JL. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral [J]. EMBO J, 1998; 17(23)∶6776.
|
2. |
Steinmetz R, Wagoner HA, Zeng P, et al. Mechanisms regulating the constitutive activation of the ERK signaling pathway in ovarian cancer and the effect of RNAi for ERK1/2 on cancer cell proliferation [J]. Mol Endocrino, 2004; 15(3)∶1004.
|
3. |
Wu TT, Wang JS, Jiaan BP, et al. Role of p21(WAF1) and p27(KIP1) in predicting biochemical recurrence for organ-confined prostate adenocarcinoma [J]. J Chin Med Assoc, 2007; 70(1)∶11.
|
4. |
Handra-Luca A, Bilal H, Bertrand JC, et al. Extra-cellular signal-regulated ERK-1/ERK-2 pathway activation in human salivary gland mucoepidermoid carcinoma: association to aggressive tumor behavior and tumor cell proliferation [J]. Am J Pathol, 2003; 163(3)∶957.
|
5. |
Hoshino R, Chatani Y, Yamori T, et al. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors [J]. Oncogene, 1999; 18(3)∶813.
|
6. |
Mishima K, Inoue K, Hayashi Y. Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma [J]. Oral Oncol, 2002; 38(5)∶468.
|
7. |
郑铭, 张幼怡, 韩启德. β肾上腺素受体的丝裂原活化蛋白激酶信号途径 [J]. 生理科学进展, 2003; 33(2)∶111.
|
8. |
Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions [J]. Biochem J, 2000; 351(Pt 2)∶289.
|
9. |
Gysin S, Lee SH, Dean NM, et al. Pharmacologic inhibition of RAF→MEK→ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1 [J]. Cancer Res, 2005; 65(11)∶4870.
|
10. |
Ito Y, Sasaki Y, Horimoto M, et al. Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma [J]. Hepatology, 1998; 27(4)∶951.
|
11. |
Adeyinka A, Nui Y, Cherlet T, et al. Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression [J]. Clin Cancer Res, 2002; 8(6)∶1747.
|
12. |
Albanell J, Codony-Servat J, Rojo F, et al. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments [J]. Cancer Res, 2001; 61(17)∶6500.
|
13. |
Uzgare AR, Kaplan PJ, Greenberg NM. Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer [J]. Prostate, 2003; 55(2)∶128.
|
14. |
Rincon-Arano H, Rosales R, Mora N, et al. R-Ras promotes tumor growth of cervical epithelial cells [J]. Cancer, 2003; 97(3)∶575.
|
15. |
Gioeli D, Mandell JW, Petroni GR, et al. Activation of mitogen-activated protein kinase associated with prostate cancer progression [J]. Cancer Res, 1999; 59(2)∶279.
|
16. |
Anders M, Christian C, McMahon M, et al. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells [J]. Cancer Res, 2003; 63(9)∶2088.
|
17. |
Wen J, Zhang Y, Chen X, et al. Enhancement of diallyl disulfide-induced apoptosis by inhibitors of MAPKs in human HepG2 hepatoma cells [J]. Biochem Pharmacol, 2004; 68(2)∶323.
|
18. |
黄辰, 刘利英, 宋土生, 等. siRNA介导的MAPK p42沉默诱导HeLa细胞凋亡 [J]. 南方医科大学学报, 2006; 26(1)∶11.
|
19. |
Tamemoto H, Kadowaki T, Tobe K, et al. Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells [J]. J Biol Chem, 1992; 267(28)∶20293.
|
20. |
黄辰, 刘利英, 宋土生, 等. 使用技术抑制细胞P42MAPK表达 [J]. 中华病理学杂志, 2006; 35(5)∶292.
|